Aug 16 (Reuters) - Achieve Life Sciences Inc ACHV.O
* Achieve Life Sciences Inc - Announced initiation of Cytisine clinical development program
* Achieve Life Sciences Inc - Assessment of repeat-dose pharmacokinetic parameters and Pharmacodynamics expected to commence in Q4 2017